The Portable Retinal Scanners segmentation by application delineates five primary use‑cases that collectively drive market revenue. Diabetes screening accounts for the largest share, reflecting widespread adoption in primary‑care settings where early detection of diabetic retinopathy is mandated; this segment contributes roughly 35 % of total sales. Glaucoma monitoring follows at 25 %, propelled by the need for regular intra‑ocular pressure assessment and optic‑nerve imaging in ophthalmology clinics. General ophthalmic examination represents 20 % of the market, encompassing routine retinal health checks, cataract evaluations, and age‑related macular degeneration screening. Telemedicine applications, now 15 % of the market, benefit from remote image capture and cloud‑based analysis, expanding access in underserved regions. Finally, research and development activities, though a niche at 5 %, sustain innovation pipelines and validate new algorithms, indirectly supporting growth across the other categories.